Inflammation, in general, and the NFKB pathway, in particular, are frequently activated in bladder cancer cells, communicating with different signaling pathways through transcriptional repertoire (Mukherjee et al., 2015). The gene discussed is NFKB1; the disease is urinary bladder carcinoma.